Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitination

Cell Reports Medicine · Published 2026-07-01 · DOI 10.1016/j.xcrm.2026.102920

Free full text

Authors (21)

Xuwen Lin, Qun Wang, Mengting Xu, Dianping Yu, Hongmei Hu, Qing Zhang, Jiannan Yao, Mei Xie, Hanchi Xu, Xuefeng Zang, Jia Li, Yu Chen, Linyang Li, Xiaoyu Tao, Xinru Li, Simeng Li, Shize Xie, Yating Tian, Weidong Zhang, Sanhong Liu, Xinying Xue

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Lin, X., Wang, Q., Xu, M., et al. (2026). Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitination. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2026.102920

Related articles